194 related articles for article (PubMed ID: 20920475)
1. Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes.
Barrand S; Andersen IS; Collas P
Biochem Biophys Res Commun; 2010 Oct; 401(4):611-7. PubMed ID: 20920475
[TBL] [Abstract][Full Text] [Related]
2. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
Barrand S; Collas P
Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
Freberg CT; Dahl JA; Timoskainen S; Collas P
Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
[TBL] [Abstract][Full Text] [Related]
4. Polycomb protein EED is required for silencing of pluripotency genes upon ESC differentiation.
Obier N; Lin Q; Cauchy P; Hornich V; Zenke M; Becker M; Müller AM
Stem Cell Rev Rep; 2015 Feb; 11(1):50-61. PubMed ID: 25134795
[TBL] [Abstract][Full Text] [Related]
5. Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19 embryonal carcinoma cells via directly activating Oct4.
Li H; Fan R; Sun M; Jiang T; Gong Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):527-32. PubMed ID: 24113379
[TBL] [Abstract][Full Text] [Related]
6. Global and gene-specific histone modification profiles of mouse multipotent adult germline stem cells.
Khromov T; Pantakani DV; Nolte J; Wolf M; Dressel R; Engel W; Zechner U
Mol Hum Reprod; 2011 Mar; 17(3):166-74. PubMed ID: 20935159
[TBL] [Abstract][Full Text] [Related]
7. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
[TBL] [Abstract][Full Text] [Related]
8. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation.
Wu Q; Bruce AW; Jedrusik A; Ellis PD; Andrews RM; Langford CF; Glover DM; Zernicka-Goetz M
Stem Cells; 2009 Nov; 27(11):2637-2645. PubMed ID: 19544422
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells.
Hattori N; Imao Y; Nishino K; Hattori N; Ohgane J; Yagi S; Tanaka S; Shiota K
Genes Cells; 2007 Mar; 12(3):387-96. PubMed ID: 17352742
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of gene expression in porcine epiblast, hypoblast, trophectoderm and epiblast-derived neural progenitor cells.
Gao Y; Jammes H; Rasmussen MA; Oestrup O; Beaujean N; Hall V; Hyttel P
Epigenetics; 2011 Sep; 6(9):1149-61. PubMed ID: 21975513
[TBL] [Abstract][Full Text] [Related]
11. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
12. BACH1 recruits NANOG and histone H3 lysine 4 methyltransferase MLL/SET1 complexes to regulate enhancer-promoter activity and maintains pluripotency.
Niu C; Wang S; Guo J; Wei X; Jia M; Chen Z; Gong W; Qin Y; Wang X; Zhi X; Lu M; Chen S; Gu M; Zhang J; Han JJ; Lan F; Meng D
Nucleic Acids Res; 2021 Feb; 49(4):1972-1986. PubMed ID: 33503260
[TBL] [Abstract][Full Text] [Related]
13. H3K27me3 may be associated with Oct4 and Sox2 in mouse preimplantation embryos.
Wu FR; Zhang Y; Ding B; Lei XH; Huang JC; Wang CH; Liu Y; Wang R; Li WY
Genet Mol Res; 2014 Dec; 13(4):10121-9. PubMed ID: 25501223
[TBL] [Abstract][Full Text] [Related]
14. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation.
Fouse SD; Shen Y; Pellegrini M; Cole S; Meissner A; Van Neste L; Jaenisch R; Fan G
Cell Stem Cell; 2008 Feb; 2(2):160-9. PubMed ID: 18371437
[TBL] [Abstract][Full Text] [Related]
15. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
du Puy L; Lopes SM; Haagsman HP; Roelen BA
Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
[TBL] [Abstract][Full Text] [Related]
16. A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4.
Smith JA; Ndoye AM; Geary K; Lisanti MP; Igoucheva O; Daniel R
Aging Cell; 2010 Aug; 9(4):580-91. PubMed ID: 20477760
[TBL] [Abstract][Full Text] [Related]
17. Differential methylation of pluripotency gene promoters in in vitro matured and vitrified, in vivo-matured mouse oocytes.
Milroy C; Liu L; Hammoud S; Hammoud A; Peterson CM; Carrell DT
Fertil Steril; 2011 May; 95(6):2094-9. PubMed ID: 21457962
[TBL] [Abstract][Full Text] [Related]
18. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
[TBL] [Abstract][Full Text] [Related]
19. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
Wiencke JK; Zheng S; Morrison Z; Yeh RF
Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]